IP Library › Assignment 036947/0382
Patent Assignment
Reel/Frame 036947/0382

Assignment of Assignor's Interest

Recorded: 2015-11-03 Pages: 2
Assignor
RESVERLOGIX CORP.
Executed: 2013-03-01
Assignee
RVX THERAPEUTICS INC.
202,279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property (1)
Novel Heterocyclic Compounds as Bromodomain Inhibitors
Patent: 9,271,978 →
Application: 14/134,793 →
Publication: US 2014/0179648
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
General Conveyance and Assumption Agreement Jul 14, 2014
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 033312/0422 →
Assignment of Assignor's Interest Nov 3, 2015
From: LIU, SHUANG; DUFFY, BRYAN CORDELL; JIANG, MAY XIAOWU; WANG, RUIFANG
To: RESVERLOGIX CORP.
Reel/Frame 036947/0373 →
Change of Name Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →